Biofrontera completes transfer of Ameluz and RhodoLED FDA approvals
Tweet Send to a Friend
Biofrontera Inc. (NASDAQ: BFRI) completed the transfer of FDA approvals for its Ameluz and RhodoLED Lamp Series products, including the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


